1. Home
  2. SGHT vs RILY Comparison

SGHT vs RILY Comparison

Compare SGHT & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • RILY
  • Stock Information
  • Founded
  • SGHT 2011
  • RILY 1973
  • Country
  • SGHT United States
  • RILY United States
  • Employees
  • SGHT N/A
  • RILY N/A
  • Industry
  • SGHT Medical Specialities
  • RILY Investment Managers
  • Sector
  • SGHT Health Care
  • RILY Finance
  • Exchange
  • SGHT Nasdaq
  • RILY Nasdaq
  • Market Cap
  • SGHT 193.2M
  • RILY 154.9M
  • IPO Year
  • SGHT 2021
  • RILY 2007
  • Fundamental
  • Price
  • SGHT $3.49
  • RILY $6.75
  • Analyst Decision
  • SGHT Buy
  • RILY
  • Analyst Count
  • SGHT 8
  • RILY 0
  • Target Price
  • SGHT $4.29
  • RILY N/A
  • AVG Volume (30 Days)
  • SGHT 108.2K
  • RILY 892.9K
  • Earning Date
  • SGHT 11-06-2025
  • RILY 11-13-2025
  • Dividend Yield
  • SGHT N/A
  • RILY N/A
  • EPS Growth
  • SGHT N/A
  • RILY N/A
  • EPS
  • SGHT N/A
  • RILY N/A
  • Revenue
  • SGHT $76,303,000.00
  • RILY $639,161,000.00
  • Revenue This Year
  • SGHT N/A
  • RILY N/A
  • Revenue Next Year
  • SGHT $12.04
  • RILY N/A
  • P/E Ratio
  • SGHT N/A
  • RILY N/A
  • Revenue Growth
  • SGHT N/A
  • RILY N/A
  • 52 Week Low
  • SGHT $2.03
  • RILY $2.67
  • 52 Week High
  • SGHT $7.03
  • RILY $7.43
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 49.70
  • RILY 66.63
  • Support Level
  • SGHT N/A
  • RILY $5.76
  • Resistance Level
  • SGHT $3.65
  • RILY $6.65
  • Average True Range (ATR)
  • SGHT 0.16
  • RILY 0.49
  • MACD
  • SGHT -0.19
  • RILY 0.12
  • Stochastic Oscillator
  • SGHT 82.12
  • RILY 97.94

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: